Abstract-The effects of intraperitoneal injections of various doses of A9-tettahydrocannabinol (A"-THC) on brain levels of cyclic adenosine 3',5'-monophosphate (cyclic AMP) have been studied in mice. Doses of A9-THC in the range of 0.1 to 1.0 mgikg cause a 5&160 per cent elevation of cyclic AMP levels compared to controls (P < O.OOOS), while doses of A9-THC in the range of 2.0 to 10.0 mg/kg cause a 3@-60 per cent depression of cyclic AMP levels (P = 0.025 to 0.0005). This pattern was obtained in whole brain, as well as in dissected samples of cortex, cerebellum and medulla. This over-all biphasic effect of THC on cyclic AMP levels correlates with known changes in biogenic amines, temperature regulation, and behavior caused by this drug.
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NUMEROUS investigators
have demonstrated that tetrahydrocannabinol (THC) and at least one of its metabolites, 1 l-OH-THC, are the major compounds responsible for the psychomimetic action of marihuana in mammalian systems. 'L' 4 Although the molecular mechanism of THC action is still unknown, evidence has accumulated suggesting that the effects of Cannabis may be mediated. at least in part, by alterations in biogenic amines. Moderate doses of THC or Cannabis extracts in rodents have been reported to produce an elevation in brain levels of serotonin' 5p19 and a depression of norepinephrine,'b~'7. 20 5-hydroxyindole acetic acid and normetaephrine. 21 In view of the importance of these biogenic amines as neurohumors affecting behavior and mood, it seems reasonable to speculate that these changes in brain amines are in some way involved in the behavioral effects of marihuana.
Some biogenic amines are now thought to transmit their effects via an activation of the membrane-associated enzyme adenyl cyclase, resulting in the synthesis of cyclic adenosine 3',5'-monophosphate (cyclic AMP variety of behavioral changes, including increased locomotor activity, catatonia and convulsions. 30 From these types of data it appears that cyclic AMP may be intimately involved in mediating the effects of brain amines on behavior. In view of the reported changes in both biogenic amines and behavior induced by the administration of active ingredients of marihuana such as A9-THC, it seemed appropriate to attempt to determine whether some ofthe effects of this drug are also mediated by changes in cyclic AMP. The present studies show that significant alterations in brain levels of cyclic AMP are induced by administration of THC to mice. Low doses of THC cause an increase in cyclic AMP levels, while at high doses of THC, the levels of cyclic AMP are depressed. This over-all biphasic effect correlates with reported changes in both biogenie amines and behavior patterns.
MATERIALS

AND METHODS
~2~rrterial.s. 32 The animals were decapitated, the heads chilled and the brain was dissected into the medulla oblongata, cerebellum. hypothalamus and remainder (labeled cortex) as described in Clowinski and Iversen."3 Each brain region was homogenized in l-3 ml of 10% trichloroacetic acid with ten strokes of a glass Teflon homogenizer at 7O~rev/min. The resulting homogenate was centrifuged at lO.OOOy for 20 min and the supernatant collected. The homogenate pellet was extracted with 5 vol. of 20% ethanol in ether prior to a modified Koch--Putnam biuret protein determination34 using 1: 3 proportion of 1 N sodium hydroxide to biuret reagent. Duplicate aliquots of the supernatant from each brain region (0.1 to 0.3 ml) were extracted four times with 20 vol. of ether (saturated with 1.0 N HCI) to remove the TCA prior to the assay of cyclic AMP. Extraction was performed by vortexing for 30 set in I2 ml acid-washed conical tubes. The extracted aqueous aliquot was, dried in a vacuum desicator overnight and resuspended in 50 mM sodium acetate buffer at the time of the assay of cyclic AMP. Tracer 3H-cyclic AMP added to sample brain regions and carried through the procedure showed no counts soluble in the ether phases and a cyclic AMP recovery of approximately 90 per cent.
PI.otc~in-hirzdinU us.sa~~ji~r cyclic AMP. The cyclic AMP-dependent protein kinase was isolated from bovine forelimb muscle employing the procedure of Miyamoto clt ~1.~~ through the DEAE-cellulose chromatography step. Cyclic AMP was assayed according to the protein-binding method of Gilman. Briefly, a standard curve was generated by incubating various concentrations of unlabeled cyclic AMP (O-500 nM) with 16.6 nM 3H-cyclic AMP, 1 pg protein kinase binding protein (peak I from DEAE-cellulose column), 10~1 of inhibitor as isolated by Appleman rt u/..~' and 50 mM sodium acetate, pH 4.0, in a volume of 0.1 ml for 2 hr at 4 . Concommitantly, unknowns were incubated with all of the preceding components with the exception of unlabeled cyclic AMP. After 2 hr, the contents of each tube were filtered through a multiple membrane filtering apparatus. and the filters dried and counted in toluene scintillation mixture at 32 per cent efficiency. An IBM 360 computer was employed to generate a regression equation by the method of least squares for the standard curve, and the unknown samples were solved employing regression. Assa)~ of adenyl cyclase and phosphoniesterase.
Adenyl After 10 min of incubation at 37', 0.8 ml of 50 per cent settled volume of an aqueous slurry of AGl-X2 20&400 mesh anion exchange resin was added to the vials, which were then reincubated for an additional 10 min to absorb the unreacted cyclic AMP. Ten ml of Bray's scintillation mixture was then added and the free radioactive adenosine determined by liquid scintillation counting.
Recovery of injected THC in mouse brain. In order to determine the amount of THC which actually reaches the brain after intraperitoneal injection, recovery studies were performed after intraperitoneal injections of radioactive THC (7.14 mgikg of 3H-THC, sp. act. = 109 &i/mg).
Thirty min post-injection, the animals were sacrificed by exposure to microwave irradiation for 30 set, and the brain regions removed and homogenized twice with 5.0-ml portions of ethyl acetate using a Polytron homogenizer for 20 set at maximum speed. The resulting homogenate was centrifuged at 850g for 5 min and the ethyl acetate phases were pooled and evaporated under nitrogen. The soluble counts were taken up in a small volume of ethanol, spotted on Silica gel G thin-layer chromatography plates along with standards of A"-THC, and developed with hexane-acetone (3: 1). The developed plates were cut in 1 cm' blocks and counted in toluene scintillation mixture at 32 per cent efficiency.
RESULTS
Protein-binding ussuyfbr cyclic AMP. The preparation of the cyclic AMP binding protein which we obtained was found to have a dissociation constant of 7 x lo-" M, and at saturation bound 0.6 pmole radioactive cylic AMP/pg of protein. The standard curves obtained were found to have a standard deviation of less than 8 per cent when unlabeled cyclic AMP concentrations were in the range of 0.8 pmole to 5 pmole/O.l ml of assay mixture. Standard curves with unlabeled cyclic GMP as competitor for radioactive cyclic AMP binding showed this nucleotide to be only l/30 as effective as unlabeled cyclic AMP in competing for 1 pg of the binding protein. Other nucleotides such as cyclic UMP and cyclic CMP were found to compete even less (l/60) than cyclic GMP.
Fixatiorl of cyclic AMP levels by microwuce irradiation. Numerous investigators have reported that when animals are sacrificed by decapitation, endogenous cyclic AMP levels in brain are elevated 2-to lo-fold within l-3 min.31,32,36 To prevent such post-mortem changes from occurring, we employed microwave irradiation as a technique for sacrificing animals. As can be seen from the data in Table 1 , this technique inactivates both adenyl cyclase and phosphodiesterase, thus preventing the dramatic changes in cyclic AMP levels seen after decapitation.
Recocery of 3H-THC in brain after intraperitoneal injection. Since other investiga-
tors have reported relatively poor absorption of THC after intraperitoneal injection,40 we performed some recovery experiments with radioactive THC in order to determine how much of our injected dose was reaching the brain. Thirty min after intraperitoneal injection of 7.14 mg/kg of 3H-THC, 0.07 per cent of the total radioactivity was recoverable in the brain. Assuming that 80 per cent of the wet brain weight is water. this converts to a concentration of approximately 4.X x lo-4 M. This concentration is within the normal range of THC found in the blood and brain of mammals, as calculated from other studies using various routes of administration and employing behavioral tests as criteria for effective dose."."',"' IZfict'ccts of THC on brain 1evel.s qf'cyclic AMP. The effects of injecting various doses of A9-THC on whole brain levels of cyclic AMP arc summarized in Fig. 1 be seen, the predominant effect of A9-THC on cyclic AMP levels is an elevation (5G 160 per cent) above controls at doses between 01 and 1.0 mg/kg, and a depression (3&60 per cent) of cyclic AMP levels at doses between 2.0 and 10 mg/kg. Superimposed on this general trend is a statistically significant variation in cyclic AMP levels in the low dose range which involves a primary stimulation (0.1 mg/kg), then a depression (0.25 to 0.5 mg/kg), followed by a secondary stimulation (1.0 mg/kg). At the highest dose of A9-THC tested (50 mg/kg), cyclic AMP levels were not significantly altered. Table 2 summarizes the results of statistical analyses performed to determine the significance of the observed trends. As can be seen, the elevations of cyclic AMP levels observed with doses of A9-THC from 0.1 to 1.0 mg/kg, and the depressions of cyclic AMP observed with doses of A9-THC from 2.0 and 100 mg/kg are all significant (P = 0.025 to 0.0005). In this context, it should be noted that measured levels of cyclic AMP in control animals varied some 20 * N is the number of animals tested, each assayed in duplicate. t P values generated from the statistical method for testing the difference between two populations with the population variance unknown but assumed equal, significance for one-sided upper tail hypothesis test.
to run a new set of control animals with each new experiment, since only in this way can the effects of the drug treatment be reliably determined. Therefore, each individual experiment was performed with several doses and a control group, and the data were normalized to the arithmetic mean of the pooled control groups. In order to determine whether the observed effects of THC administration on whole brain cyclic AMP levels could be localized to any particular brain areas, cyclic AMP assays were performed on dissected regions of the brain. As is shown in Table  3 , the cortex, medulla and cerebellum follow the same general biphasic pattern as that of whole brain, except the stimulation of cyclic AMP by A9-THC becomes less significant at doses of 0.25 to 1.0 mg/kg in these regions when compared to that of whole brain. Nevertheless, there is a persistently significant elevation of cyclic AMP in these regions at 0.1 mg/kg of A9-THC. The values for hypothalamus did not exhibit a clear pattern, although the statistically most significant points (0.25 mg/kg and 2.0 mg/kg) suggest a trend in the opposite direction, namely depression of cyclic AMP followed by elevation.
DISCUSSION
The present results clearly demonstrate that administration of A9-THC exerts an over-all biphasic effect on brain levels of cyclic AMP, with doses less than 2.0 mg/kg inducing an elevation of cyclic AMP levels and doses of 2.0 mg/kg and greater causing a depression of cyclic AMP. The existence of a secondary stimulation of cyclic AMP levels at 1.0 mg/kg in the whole brain indicates a complex interaction of A9-THC with the cyclic AMP regulatory systems, and suggests that more than one mode of action may be involved.
These general results can be correlated with observations of other investigators on the effects of A9-THC on brain levels of biogenic amines. For example, Holtzman et al." observed that serotonin levels were increased and norepinephrine levels were decreased by intraperitoneal injections of A9-THC in the dose range of 5-50 mg/kg. Using intravenous injection, Ho et al." also found that relatively high doses of THC cause an elevation of serotonin and depression of norepinephrine levels. However, with smaller doses (less than 2 mg/kg) they observed the opposite effects, namely a decrease in serotonin and an elevation of norepinephrine. Thus, the presently observed biphasic effect of THC on cyclic AMP levels is parallel to the effects of THC on brain norepinephrine levels, and is inversely related to THC-induced changes in serotonin levels.
Biphasic effects of THC have also been observed on other parameters. For example, Sofia43 has reported a biphasic effect of THC on rectal temperature in rats, with low doses (0.5 to 1.0 mg/kg) producing hyperthermia and high doses (4 8 mg/kg) causing a marked hypothermia.
Biphasic effects of THC on behavioral reponses have also been reported, with low doses causing excitation and increased response rate, while higher doses produce decreased motility and suppression of response rate. [44] [45] [46] The similarity of these reported biphasic effects of THC on biogenic amines, temperature regulation, and behavior with the presently reported observation of a biphasic effect of THC on brain cyclic AMP levels suggests that these findings may be all interrelated.
Especially significant is the observed correlation with behavioral responses, since it is changes in behavior induced by THC which are most directly rele-vant to any discussions of the effects of marihuana in man. These data suggest, then, that the THC-induced changes in cyclic AMP may be involved in the behavioral effects of this drug. There is some direct support for this conclusion available in the studies of Gessa LJ~ aL3" who demonstrated that microinjection of dibutyryl cyclic AMP into the lateral ventricles or the hypothalamus produces psychomotor stimulation, while injection into the recticular formation causes catatonia. It is interesting to note that these behavioral patterns are similar to those described by several investigators as occurring over time after a high initial dose of THC.2.'7.47 namely excitation followed by catatonia or depression. Other indirect evidence suggesting a relationship between psychological state and cyclic AMP can be found in the reports that urinary excretion of cyclic AMP is elevated in manic patients and lowered in patients with severe depression."8~49
The present data raise the obvious critical question as to the mechanism via which THC induces an alteration of cyclic AMP levels. One can distinguish at least two general levels at which THC might be acting. One possibility would be an indirect effect resulting from an alteration in biogenic amine metabolism and/or transport. Since biogenic amines are known to stimulate the formation of cyclic AMP, any changes in biogenic amines caused by THC could, in turn, affect cyclic AMP levels. In addition to this relatively indirect mode of action, the other general way in which THC might be acting would be directly on the enzymes involved in cyclic AMP formation and breakdown, namely adenyl cyclase and phosphodiesterase. In regard to the first possibility, namely an indirect mechanism of action, evidence is now available which suggests that THC can inhibit the uptake and turnover of serotonin and norepinephrine in brain particulate fractions5"~"' Although data is available which suggests that THC does not affect at least one enzyme of biogenic amine metabolism.
namely monoamine oxidase,18 data for other enzymes arc not available. In regard to the second possibility of direct effects of THC on the cyclic AMP system itself, changes in adenyl cyclase and phosphodiesterase in response to THC have not yet been observed. Since a resolution of THC-induced alterations in cyclic AMP may be of major importance for understanding marihuana action, experiments along these lines are currently being pursued in our laboratory.
